The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model
To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm. Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate wer...
Gespeichert in:
Veröffentlicht in: | Turkish neurosurgery 2020-01, Vol.30 (2), p.163-170 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 170 |
---|---|
container_issue | 2 |
container_start_page | 163 |
container_title | Turkish neurosurgery |
container_volume | 30 |
creator | Eser, Muhammed Taha Bektasoglu, Pinar Kuru Gurer, Bora Bozkurt, Huseyin Sorar, Mehmet Ozturk, Ozden Caglar Arikok, Ata Turker Kertmen, Hayri |
description | To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm.
Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate were intraperitoneally administered 5 minutes after the procedure and continued for 3 days as daily administrations of the same dose. At the end of the third day, the cerebrum, cerebellum, and brain stem were perfused, fixated, and removed for histopathological examination. Tissues were examined for arterial wall thickness, luminal area, and hippocampal neuronal degeneration.
Mildronate group showed significantly increased luminal area and reduced wall thickness of the basilar artery compared with the subarachnoid hemorrhage group. In addition, the hippocampal cell degeneration score was significantly lower in the mildronate group than in the SAH and vehicle groups.
These results show that mildronate exerts protective effects against SAH-induced vasospasm and secondary neural injury. |
doi_str_mv | 10.5137/1019-5149.JTN.24647-18.3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2375915235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2375915235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-613b48dd21d84def0c07390283c0c39e238609edeb43a3f0b06da093f05f9e203</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRb0A0VL4BeQlmwQ_8vKyqgoFtUWCwtZy4jENSuJiJwj-HhdKVzPSvXceByFMSZxSnt9QQkWU0kTED5t1zJIsySNaxPwEjY_SCJ17_05IljFKz9CIM5oyIcQY6c0W8Kvy1kGjvlTXY9VpvIbB2Z2zPVR9_Ql4bkzoPLYGr-pGO9upHnDd4Sl-UmVZ9_h5KJVT1baztcYLaK1zW_UGeGU1NBfo1KjGw-WhTtDL7XwzW0TLx7v72XQZVSwjfZRRXiaF1ozqItFgSEVyLggreEUqLoDxIiMCNJQJV9yQkmRaERG61ASV8Am6_psbTv8YwPeyrX0FTaM6sIOXjOepCJ_zNFiLP2vlrPcOjNy5ulXuW1Ii91zlHp7cw5OBq_zlKmkheYheHbYMZQv6GPyHyn8AvOx2mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2375915235</pqid></control><display><type>article</type><title>The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Eser, Muhammed Taha ; Bektasoglu, Pinar Kuru ; Gurer, Bora ; Bozkurt, Huseyin ; Sorar, Mehmet ; Ozturk, Ozden Caglar ; Arikok, Ata Turker ; Kertmen, Hayri</creator><creatorcontrib>Eser, Muhammed Taha ; Bektasoglu, Pinar Kuru ; Gurer, Bora ; Bozkurt, Huseyin ; Sorar, Mehmet ; Ozturk, Ozden Caglar ; Arikok, Ata Turker ; Kertmen, Hayri</creatorcontrib><description>To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm.
Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate were intraperitoneally administered 5 minutes after the procedure and continued for 3 days as daily administrations of the same dose. At the end of the third day, the cerebrum, cerebellum, and brain stem were perfused, fixated, and removed for histopathological examination. Tissues were examined for arterial wall thickness, luminal area, and hippocampal neuronal degeneration.
Mildronate group showed significantly increased luminal area and reduced wall thickness of the basilar artery compared with the subarachnoid hemorrhage group. In addition, the hippocampal cell degeneration score was significantly lower in the mildronate group than in the SAH and vehicle groups.
These results show that mildronate exerts protective effects against SAH-induced vasospasm and secondary neural injury.</description><identifier>ISSN: 1019-5149</identifier><identifier>DOI: 10.5137/1019-5149.JTN.24647-18.3</identifier><identifier>PMID: 32152999</identifier><language>eng</language><publisher>Turkey</publisher><ispartof>Turkish neurosurgery, 2020-01, Vol.30 (2), p.163-170</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32152999$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eser, Muhammed Taha</creatorcontrib><creatorcontrib>Bektasoglu, Pinar Kuru</creatorcontrib><creatorcontrib>Gurer, Bora</creatorcontrib><creatorcontrib>Bozkurt, Huseyin</creatorcontrib><creatorcontrib>Sorar, Mehmet</creatorcontrib><creatorcontrib>Ozturk, Ozden Caglar</creatorcontrib><creatorcontrib>Arikok, Ata Turker</creatorcontrib><creatorcontrib>Kertmen, Hayri</creatorcontrib><title>The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model</title><title>Turkish neurosurgery</title><addtitle>Turk Neurosurg</addtitle><description>To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm.
Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate were intraperitoneally administered 5 minutes after the procedure and continued for 3 days as daily administrations of the same dose. At the end of the third day, the cerebrum, cerebellum, and brain stem were perfused, fixated, and removed for histopathological examination. Tissues were examined for arterial wall thickness, luminal area, and hippocampal neuronal degeneration.
Mildronate group showed significantly increased luminal area and reduced wall thickness of the basilar artery compared with the subarachnoid hemorrhage group. In addition, the hippocampal cell degeneration score was significantly lower in the mildronate group than in the SAH and vehicle groups.
These results show that mildronate exerts protective effects against SAH-induced vasospasm and secondary neural injury.</description><issn>1019-5149</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRb0A0VL4BeQlmwQ_8vKyqgoFtUWCwtZy4jENSuJiJwj-HhdKVzPSvXceByFMSZxSnt9QQkWU0kTED5t1zJIsySNaxPwEjY_SCJ17_05IljFKz9CIM5oyIcQY6c0W8Kvy1kGjvlTXY9VpvIbB2Z2zPVR9_Ql4bkzoPLYGr-pGO9upHnDd4Sl-UmVZ9_h5KJVT1baztcYLaK1zW_UGeGU1NBfo1KjGw-WhTtDL7XwzW0TLx7v72XQZVSwjfZRRXiaF1ozqItFgSEVyLggreEUqLoDxIiMCNJQJV9yQkmRaERG61ASV8Am6_psbTv8YwPeyrX0FTaM6sIOXjOepCJ_zNFiLP2vlrPcOjNy5ulXuW1Ii91zlHp7cw5OBq_zlKmkheYheHbYMZQv6GPyHyn8AvOx2mw</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Eser, Muhammed Taha</creator><creator>Bektasoglu, Pinar Kuru</creator><creator>Gurer, Bora</creator><creator>Bozkurt, Huseyin</creator><creator>Sorar, Mehmet</creator><creator>Ozturk, Ozden Caglar</creator><creator>Arikok, Ata Turker</creator><creator>Kertmen, Hayri</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200101</creationdate><title>The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model</title><author>Eser, Muhammed Taha ; Bektasoglu, Pinar Kuru ; Gurer, Bora ; Bozkurt, Huseyin ; Sorar, Mehmet ; Ozturk, Ozden Caglar ; Arikok, Ata Turker ; Kertmen, Hayri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-613b48dd21d84def0c07390283c0c39e238609edeb43a3f0b06da093f05f9e203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eser, Muhammed Taha</creatorcontrib><creatorcontrib>Bektasoglu, Pinar Kuru</creatorcontrib><creatorcontrib>Gurer, Bora</creatorcontrib><creatorcontrib>Bozkurt, Huseyin</creatorcontrib><creatorcontrib>Sorar, Mehmet</creatorcontrib><creatorcontrib>Ozturk, Ozden Caglar</creatorcontrib><creatorcontrib>Arikok, Ata Turker</creatorcontrib><creatorcontrib>Kertmen, Hayri</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Turkish neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eser, Muhammed Taha</au><au>Bektasoglu, Pinar Kuru</au><au>Gurer, Bora</au><au>Bozkurt, Huseyin</au><au>Sorar, Mehmet</au><au>Ozturk, Ozden Caglar</au><au>Arikok, Ata Turker</au><au>Kertmen, Hayri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model</atitle><jtitle>Turkish neurosurgery</jtitle><addtitle>Turk Neurosurg</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>30</volume><issue>2</issue><spage>163</spage><epage>170</epage><pages>163-170</pages><issn>1019-5149</issn><abstract>To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm.
Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate were intraperitoneally administered 5 minutes after the procedure and continued for 3 days as daily administrations of the same dose. At the end of the third day, the cerebrum, cerebellum, and brain stem were perfused, fixated, and removed for histopathological examination. Tissues were examined for arterial wall thickness, luminal area, and hippocampal neuronal degeneration.
Mildronate group showed significantly increased luminal area and reduced wall thickness of the basilar artery compared with the subarachnoid hemorrhage group. In addition, the hippocampal cell degeneration score was significantly lower in the mildronate group than in the SAH and vehicle groups.
These results show that mildronate exerts protective effects against SAH-induced vasospasm and secondary neural injury.</abstract><cop>Turkey</cop><pmid>32152999</pmid><doi>10.5137/1019-5149.JTN.24647-18.3</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1019-5149 |
ispartof | Turkish neurosurgery, 2020-01, Vol.30 (2), p.163-170 |
issn | 1019-5149 |
language | eng |
recordid | cdi_proquest_miscellaneous_2375915235 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
title | The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A03%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Vasorelaxant%20and%20Neuroprotective%20Effects%20of%20Mildronate%20in%20A%20Rabbit%20Subarachnoid%20Hemorrhage%20Model&rft.jtitle=Turkish%20neurosurgery&rft.au=Eser,%20Muhammed%20Taha&rft.date=2020-01-01&rft.volume=30&rft.issue=2&rft.spage=163&rft.epage=170&rft.pages=163-170&rft.issn=1019-5149&rft_id=info:doi/10.5137/1019-5149.JTN.24647-18.3&rft_dat=%3Cproquest_cross%3E2375915235%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2375915235&rft_id=info:pmid/32152999&rfr_iscdi=true |